These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Anaphylactoid complications related to the use of 40,000- molecular weight dextran]. Laxenaire MC; Jacob F; Noel P Ann Anesthesiol Fr; 1976; 17(2):101-4. PubMed ID: 62526 [TBL] [Abstract][Full Text] [Related]
45. A study of safer plasma substitutes. Gollub S; Vanichanan C; Schaefer C; Schechter DC Surg Gynecol Obstet; 1969 Jun; 128(6):1235-43. PubMed ID: 5781849 [No Abstract] [Full Text] [Related]
51. [Death caused by infusion of low-molecular dextran]. Plamieniak L; Kowal-Gierczak B; Kotschy M; Kurzawska M; Kozlowska B Wiad Lek; 1974 May; 27(10):901-5. PubMed ID: 4839858 [No Abstract] [Full Text] [Related]
52. [Mechanisms of anaphylactoid reactions to drugs used in anesthesiology]. Moneret-Vautrin DA Ann Anesthesiol Fr; 1977; 18(7-8):679-84. PubMed ID: 74222 [TBL] [Abstract][Full Text] [Related]
53. Mechanisms of histamine release in anaphylactic and anaphylactoid reactions. Kazimierczak W; Diamant B Prog Allergy; 1978; 24():295-365. PubMed ID: 78497 [No Abstract] [Full Text] [Related]
54. New types of synthetic infusion solutions. I. Investigation of the effect of solutions of some hydrophilic polymers on blood. Kopecek J; Sprincl L; Lïm D J Biomed Mater Res; 1973 Mar; 7(2):179-91. PubMed ID: 4267380 [No Abstract] [Full Text] [Related]
55. [Main features of the mechanism of action of plasma substitutes and typical errors in their use]. Koziner VB Gematol Transfuziol; 1983 Sep; 28(9):5-11. PubMed ID: 6195044 [No Abstract] [Full Text] [Related]
56. Renal toxicity of low molecular weight dextran: a review of the literature. Figueroa JE; Burgos-Calderon R J La State Med Soc; 1974 Dec; 126(12):425-7. PubMed ID: 4436605 [No Abstract] [Full Text] [Related]